You just read:

Doctors Would Have 18% of High-Cholesterol Patients take New PCSK9 Inhibitor Drugs Today If FDA Approves Their Use, According to New Data from InCrowd

News provided by

InCrowd

Jun 12, 2015, 06:00 ET